Cancer Signaling Pathways

IsoPlexis' precision development and pathway monitoring are advancing targeting in Cancer Signaling Pathways

Discover sources of resistance to Cancer Signaling Pathway therapies by understanding single-cell pathways that translate to therapeutic insights

IsoPlexis detects the key intracellular pathways in tumor cells that can uncover critical and unseen targets in oncology, helping you understand earlier in development the impacts of your therapies, and also mechanisms behind patient resistance in oncology research.

Featured Webinar
Cancer Resistance Revealed Through the Single Cell Intracellular Proteome, Masked Through Bulk and Genomics
featured webinars & interviews
See how industry leaders and pioneers are revealing the true functional biology to accelerate research and medicine
Technology Webinars
Learn how to automate your entire multiplexed ELISA workflow to increase work-away time
Guest Speaker
Damini Patel, Field Application Scientist, IsoPlexis
Proteomics Webinars
Understand the pathogenesis, the role of cytokines, and the immune response in COVID-19
Guest Speaker
David Ho, MD, Scientific Director and CEO of the Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center
Automate Your Entire Workflow With One System
ONE INSTRUMENT & Workflow Step
The IsoLight
Data visualization software
Proteomic Barcoded Chips
IsoCode & CodePlex